1. Home
  2. DNA vs OFIX Comparison

DNA vs OFIX Comparison

Compare DNA & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • OFIX
  • Stock Information
  • Founded
  • DNA 2008
  • OFIX 1987
  • Country
  • DNA United States
  • OFIX United States
  • Employees
  • DNA N/A
  • OFIX N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • OFIX Medical/Dental Instruments
  • Sector
  • DNA Health Care
  • OFIX Health Care
  • Exchange
  • DNA Nasdaq
  • OFIX Nasdaq
  • Market Cap
  • DNA 466.4M
  • OFIX 440.0M
  • IPO Year
  • DNA N/A
  • OFIX N/A
  • Fundamental
  • Price
  • DNA $7.00
  • OFIX $11.04
  • Analyst Decision
  • DNA Sell
  • OFIX Strong Buy
  • Analyst Count
  • DNA 3
  • OFIX 3
  • Target Price
  • DNA $9.67
  • OFIX $23.33
  • AVG Volume (30 Days)
  • DNA 1.1M
  • OFIX 504.7K
  • Earning Date
  • DNA 05-06-2025
  • OFIX 05-06-2025
  • Dividend Yield
  • DNA N/A
  • OFIX N/A
  • EPS Growth
  • DNA N/A
  • OFIX N/A
  • EPS
  • DNA N/A
  • OFIX N/A
  • Revenue
  • DNA $237,417,000.00
  • OFIX $804,529,000.00
  • Revenue This Year
  • DNA N/A
  • OFIX $4.01
  • Revenue Next Year
  • DNA $15.26
  • OFIX $6.08
  • P/E Ratio
  • DNA N/A
  • OFIX N/A
  • Revenue Growth
  • DNA 13.76
  • OFIX 5.85
  • 52 Week Low
  • DNA $5.00
  • OFIX $10.50
  • 52 Week High
  • DNA $23.29
  • OFIX $20.73
  • Technical
  • Relative Strength Index (RSI)
  • DNA 45.07
  • OFIX 29.59
  • Support Level
  • DNA $6.90
  • OFIX $10.95
  • Resistance Level
  • DNA $7.62
  • OFIX $11.72
  • Average True Range (ATR)
  • DNA 0.48
  • OFIX 0.37
  • MACD
  • DNA -0.08
  • OFIX 0.02
  • Stochastic Oscillator
  • DNA 20.00
  • OFIX 4.38

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Share on Social Networks: